Hello World!
Welcome to WordPress! This is your first post. Edit or delete it to
The future of Cancer Treatment Is just around the corner
Thunder Biotech is developing MOTO-CAR™ Immunotherapy, genetically engineered macrophages, that help cancer patients’ immune cells recognize and attack solid tumors.
Empowering Patients to Conquer Cancer
When someone develops cancer, two things have happened: mutated cells accumulate and the body’s immune system has failed to identify and eliminate them. It’s these unchecked, mutated cells that become cancer cells. Thunder Biotech is developing new therapies that help re-educate a patient’s immune system, restoring its ability to recognize and destroy cancer cells.
The ThunderBiotech Pipeline
The Promise of MOTO-CAR™ Immunotherapy
Traditional cancer treatments, including surgery, radiation, and chemotherapy, are invasive procedures that patients often find difficult to tolerate.
Thunder Biotech is working toward a more compassionate and effective cancer treatment. We are developing innovative MOTO-CAR™ immunotherapy treatments, which hold the promise of attacking solid tumors by activating a patient’s own immune system to eliminate cancer.
MOTO-CAR™ Immunotherapy
Thunder Biotech is a cancer immunotherapy company that has patented innovative treatments for cancer. This therapy genetically engineers a patient’s own immune cells (macrophages) into MOTO-CAR™s, which target specific biomarkers present on the surface of tumor cells. These MOTO-CAR™ have the ability both to identify cancer cells and to engage the patient’s immune system to attack and destroy tumor cells.
This novel technology, developed by ThunderBiotech, has tremendous potential to help patients conquer cancer. With this new approach to fighting an old disease, Thunder Biotech is emerging as a leader in CAR (Chimeric Antigen Receptor) macrophage immunotherapy cancer treatment.
0
Years Of Experience
Disrupting cancer treatment norms to deliver better patient outcomes
We are leveraging the natural power of macrophages by engineering them to attack tumors. MOTO-CAR™s (chimeric antigen receptor macrophages) can eat away at tumors and lead to long-term, anti-tumor immunity, giving patients a promising future.
0
Professional Staff
0
Types of MOTO-CAR™s
0
Specialist
Help Us Conquer Cancer
Cancer claims millions of lives each year. In the United States, approximately 600,000 people die from cancer every year, which is almost one person every minute. Worldwide, approximately 10 million people die each year from cancer — more than 19 deaths per minute.
It is very likely that you or someone you personally know and love has been diagnosed with cancer.
Help Us Conquer Cancer
Cancer claims millions of lives each year. In the United States, approximately 600,000 people die from cancer every year, which is almost one person every minute. Worldwide, approximately 10 million people die each year from cancer — more than 19 deaths per minute.
It is very likely that you or someone you personally know and love has been diagnosed with cancer.
News & Article
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis.